Abstract
Background
Sudden cardiac death is a natural and unexpected death that occurs within 1 h of the first symptom. Most sudden cardiac deaths occur during exercise, mostly as a result of myocardial infarction. After autopsy, some cases, especially in the young, are diagnosed as cardiomyopathies or remain without a conclusive cause of death. In both situations, genetic alterations may explain the arrhythmia.
Objective
Our aim was to identify a genetic predisposition to sudden cardiac death in a cohort of post-mortem cases of individuals who died during exercise, with a structurally normal heart, and were classified as arrhythmogenic death.
Methods
We analyzed a cohort of 52 post-mortem samples from individuals <50 years old who had a negative autopsy. Next-generation sequencing technology was used to screen genes associated with sudden cardiac death.
Results
Our cohort showed a male prevalence (12:1). Half of the deaths occurred in individuals 41–50 years of age. Running was the most common exercise activity during the fatal event, accounting for 46.15% of cases. Genetic analysis identified 83 rare variants in 37 samples (71.15% of all samples). Of all rare variants, 36.14% were classified as deleterious, being present in 53.84% of all cases.
Conclusions
A comprehensive analysis of sudden cardiac death-related genes in individuals who died suddenly while exercising enabled the identification of potentially causative variants. However, many genetic variants remain of indeterminate significance, thus further work is needed before clinical translation. Nonetheless, comprehensive genetic analysis of individuals who died during exercise enables the detection of potentially causative variants and helps to identify at-risk relatives.
Similar content being viewed by others
References
Adabag AS, Luepker RV, Roger VL, Gersh BJ. Sudden cardiac death: epidemiology and risk factors. Nat Rev Cardiol. 2010;7:216–25.
Adabag AS, Peterson G, Apple FS, et al. Etiology of sudden death in the community: results of anatomical, metabolic, and genetic evaluation. Am Heart J. 2010;159:33–9.
Maron BJ, Shirani J, Poliac LC, et al. Sudden death in young competitive athletes: clinical, demographic, and pathological profiles. JAMA. 1996;276:199–204.
Maron BJ, Udelson JE, Bonow RO, et al. Eligibility and disqualification recommendations for competitive athletes with cardiovascular abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: a scientific statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132:e273–80.
Cecchi F, Olivotto I, Baldi M, et al. Myocardial hypoperfusion due to microvascular dysfunction in hypertrophic cardiomyopathy: role of positron emission tomography. Zhonghua Xin Xue Guan Bing Za Zhi. 2009;37:1069–73.
Kelley-Hedgepeth A, Maron MS. Imaging techniques in the evaluation and management of hypertrophic cardiomyopathy. Curr Heart Fail Rep. 2009;6:135–41.
Mellor G, Behr ER. Sudden unexplained death: treating the family. Arrhythm Electrophysiol Rev. 2014;3:156–60.
Mazzanti A, O’Rourke S, Ng K, et al. The usual suspects in sudden cardiac death of the young: a focus on inherited arrhythmogenic diseases. Expert Rev Cardiovasc Ther. 2014;12:499–519.
Chiu PK, Teoh JY, Chan SY, et al. Role of PSA density in diagnosis of prostate cancer in obese men. Int Urol Nephrol. 2014;46:2251–4.
Winkel BG, Holst AG, Theilade J, et al. Nationwide study of sudden cardiac death in persons aged 1–35 years. Eur Heart J. 2011;32:983–90.
Locatelli F, Marcelli D, Comelli M, et al. Proteinuria and blood pressure as causal components of progression to end-stage renal failure: Northern Italian Cooperative Study Group. Nephrol Dial Transplant. 1996;11:461–7.
Puranik R, Chow CK, Duflou JA, et al. Sudden death in the young. Heart Rhythm. 2005;2:1277–82.
Lucarelli G, Clift RA, Galimberti M, et al. Marrow transplantation for patients with thalassemia: results in class 3 patients. Blood. 1996;87:2082–8.
Van Damme H, Gillain D, Desiron Q, et al. Kinking of the internal carotid artery: clinical significance and surgical management. Acta Chir Bel. 1996;96:15–22.
Bonati A, Albertini R, Garau D, et al. BCL2 oncogene protein expression in human hematopoietic precursors during fetal life. Exp Hematol. 1996;24:459–65.
Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. 2001;50:399–408.
Velescu A, Clara A, Penafiel J, et al. Adding low ankle brachial index to classical risk factors improves the prediction of major cardiovascular events: the REGICOR study. Atherosclerosis. 2015;241:357–63.
Winearls J, Reade M, Miles H, et al. Targeted coagulation management in severe trauma: the controversies and the evidence. Anesth Analg. 2016;123:910–24.
Seo KS, Kim JW, Park JY, et al. Role of a new intimin/invasin-like protein in Yersinia pestis virulence. Infect Immun. 2012;80:3559–69.
Hadi R, Mohanti BK, Pathy S, et al. Gastric cancer: a retrospective analysis from AIIMS, New Delhi. Gulf J Oncol. 2012;12:11–6.
Mountantonakis S, Deo R. Biomarkers in atrial fibrillation, ventricular arrhythmias, and sudden cardiac death. Cardiovasc Ther. 2012;30:e74–80.
Schwab S, Aschoff A, Spranger M, et al. The value of intracranial pressure monitoring in acute hemispheric stroke. Neurology. 1996;47:393–8.
Campuzano O, Allegue C, Partemi S, et al. Negative autopsy and sudden cardiac death. Int J Legal Med. 2014;128:599–606.
Sinard JH. Accounting for the professional work of pathologists performing autopsies. Arch Pathol Lab Med. 2013;137:228–32.
Campuzano O, Sanchez-Molero O, Allegue C, et al. Post-mortem genetic analysis in juvenile cases of sudden cardiac death. Forensic Sci Int. 2014;245C:30–7.
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405–24.
Miles MA, Shekhar TM, Hall NE, Hawkins CJ. TRAIL causes deletions at the HPRT and TK1 loci of clonogenically competent cells. Mutat Res. 2016;787:15–31.
Luo C, Deng Z, Li L, et al. Association of rituximab with graphene oxide confers direct cytotoxicity for CD20-positive lymphoma cells. Oncotarget. 2016;7:12806–22.
Wright EC, Miles JR, Lents CA, Rempel LA. Uterine and placenta characteristics during early vascular development in the pig from day 22 to 42 of gestation. Anim Reprod Sci. 2016;164:14–22.
Miles TP, Allegra JC, Ezeamama A, et al. In a longevity society, loss and grief are emerging risk factors for health care use: findings from the health and retirement survey cohort aged 50 to 70 years. Am J Hosp Palliat Care. 2016;33:41–6.
Rabbani F, Perveen S, Aftab W, et al. Health workers’ perspectives, knowledge and skills regarding community case management of childhood diarrhoea and pneumonia: a qualitative inquiry for an implementation research project “Nigraan” in District Badin, Sindh, Pakistan. BMC Health Serv Res. 2016;16:462.
Dawe DE, Christiansen D, Swaminath A, et al. Chemoradiotherapy versus radiotherapy alone in elderly patients with stage III non-small cell lung cancer: a systematic review and meta-analysis. Lung Cancer. 2016;99:180–5.
Neubauer J, Haas C, Bartsch C, et al. Erratum to: post-mortem whole-exome sequencing (WES) with a focus on cardiac disease-associated genes in five young sudden unexplained death (SUD) cases. Int J Legal Med. 2016;130:1023.
Maestri RN, Nunes ML. The uptake of safe infant sleep practices by Brazilian pediatricians: a nationwide cross-sectional survey. Sleep Med. 2016;20:123–8.
Sousa M, Gomes A, Pignatelli N, Nunes V. Massive gastrointestinal bleeding after chemotherapy for gastric lymphoma. Int J Surg Case Rep. 2016;21:41–3.
Van Driest SL, Wells QS, Stallings S, et al. Association of arrhythmia-related genetic variants with phenotypes documented in electronic medical records. JAMA. 2016;315:47–57.
Williams AR, Olfson M, Galanter M. Assessing and improving clinical insight among patients “in denial”. JAMA Psychiatry. 2015;72:303–4.
Tan N, Amendola LM, O’Daniel JM, et al. Is “incidental finding” the best term? A study of patients’ preferences. Genet Med. 2017;19(2):176–81.
Rosenthal EA, Makaryan V, Burt AA, et al. Association between absolute neutrophil count and variation at TCIRG1: the NHLBI Exome Sequencing Project. Genet Epidemiol. 2016;40:470–4.
Bush WS, Crosslin DR, Owusu-Obeng A, et al. Genetic variation among 82 pharmacogenes: the PGRNseq data from the eMERGE network. Clin Pharmacol Ther. 2016;100:160–9.
Basso C, Burke M, Fornes P, et al. Guidelines for autopsy investigation of sudden cardiac death. Virchows Arch. 2008;452:11–8.
Wilhelm M, Bolliger SA, Bartsch C, et al. Sudden cardiac death in forensic medicine: Swiss recommendations for a multidisciplinary approach. Swiss Med Wkly. 2015;145:w14129.
Miles CJ, Behr ER. The role of genetic testing in unexplained sudden death. Transl Res. 2016;168:59–73.
Stattin EL, Westin IM, Cederquist K, et al. Genetic screening in sudden cardiac death in the young can save future lives. Int J Legal Med. 2016;130:59–66.
Ackerman MJ, Priori SG, Willems S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace. 2011;13:1077–109.
Priori SG, Blomstrom-Lundqvist C. European Society of Cardiology guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death summarized by co-chairs. Eur Heart J. 2015;36:2757–9.
Rabbani B, Nakaoka H, Akhondzadeh S, et al. Next generation sequencing: implications in personalized medicine and pharmacogenomics. Mol BioSyst. 2016;12:1818–30.
Semsarian C, Ingles J, Wilde AA. Sudden cardiac death in the young: the molecular autopsy and a practical approach to surviving relatives. Eur Heart J. 2015;36:1290–6.
Skinner JR, Crawford J, Smith W, et al. Prospective, population-based long QT molecular autopsy study of postmortem negative sudden death in 1 to 40 year olds. Heart Rhythm. 2011;8:412–9.
Bagnall RD, Das KJ, Duflou J, Semsarian C. Exome analysis-based molecular autopsy in cases of sudden unexplained death in the young. Heart Rhythm. 2014;11:655–62.
Narula N, Tester DJ, Paulmichl A, et al. Post-mortem whole exome sequencing with gene-specific analysis for autopsy-negative sudden unexplained death in the young: a case series. Pediatr Cardiol. 2015;36:768–78.
Neubauer J, Haas C, Bartsch C, et al. Post-mortem whole-exome sequencing (WES) with a focus on cardiac disease-associated genes in five young sudden unexplained death (SUD) cases. Int J Legal Med. 2016;130(4):1011–21.
Nunn LM, Lopes LR, Syrris P, et al. Diagnostic yield of molecular autopsy in patients with sudden arrhythmic death syndrome using targeted exome sequencing. Europace. 2016;18:888–96.
Hertz CL, Christiansen SL, Ferrero-Miliani L, et al. Next-generation sequencing of 100 candidate genes in young victims of suspected sudden cardiac death with structural abnormalities of the heart. Int J Legal Med. 2016;130:91–102.
Cerrone M, Delmar M. Desmosomes and the sodium channel complex: implications for arrhythmogenic cardiomyopathy and Brugada syndrome. Trends Cardiovasc Med. 2014;24:184–90.
Cerrone M, Lin X, Zhang M, et al. Missense mutations in plakophilin-2 cause sodium current deficit and associate with a Brugada syndrome phenotype. Circulation. 2014;129:1092–103.
Forkmann M, Tomala J, Huo Y, et al. Epicardial ventricular tachycardia ablation in a patient with Brugada ECG pattern and mutation of PKP2 and DSP genes. Circ Arrhythm Electrophysiol. 2015;8:505–7.
Allegue C, Coll M, Mates J, et al. Genetic analysis of arrhythmogenic diseases in the era of NGS: the complexity of clinical decision-making in Brugada syndrome. PLoS One. 2015;10:e0133037.
Huang L, Tang S, Peng L, et al. Molecular autopsy of desmosomal protein plakophilin-2 in sudden unexplained nocturnal death syndrome. J Forensic Sci. 2016;61:687–91.
Olfson E, Cottrell CE, Davidson NO, et al. Identification of medically actionable secondary findings in the 1000 genomes. PLoS One. 2015;10:e0135193.
Jarvik GP, Browning BL. Consideration of cosegregation in the pathogenicity classification of genomic variants. Am J Hum Genet. 2016;98:1077–81.
Acknowledgements
The authors thank the personnel of the Institut de Medicina Legal i Ciències Forenses de Catalunya (IMLCFC) for their help in the collection of samples for the study.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
Oscar Campuzano, Olallo Sanchez-Molero, Anna Fernandez, Irene Mademont-Soler, Monica Coll, Alexandra Perez-Serra, Jesus Mates, Bernat del Olmo, Ferran Pico, Laia Nogue-Navarro, Georgia Sarquella-Brugada, Anna Iglesias, Sergi Cesar, Esther Carro, Juan Carlos Borondo, Josep Brugada, Josep Castellà, Jordi Medallo, and Ramon Brugada declare they have no conflicts of interest directly relevant to the content of this study.
Funding
This work was supported by Obra Social ‘La Caixa’, Fondo Investigacion Sanitaria (FIS PI14/01773) from the Instituto de Salud Carlos III (ISCIII), and Fundació Academia de Ciències Mèdiques i de la Salut de Catalunya i de Balears (ACMCB-2013). The CIBERCV is an initiative of the ISCIII, Spanish Ministry of Economy and Competitiveness.
Additional information
Oscar Campuzano and Olallo Sanchez-Molero authors contributed equally.
Rights and permissions
About this article
Cite this article
Campuzano, O., Sanchez-Molero, O., Fernandez, A. et al. Sudden Arrhythmic Death During Exercise: A Post-Mortem Genetic Analysis. Sports Med 47, 2101–2115 (2017). https://doi.org/10.1007/s40279-017-0705-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40279-017-0705-3